A Drug Maker Spends Big in Washington to Make Itself Heard

Friday, July 21, 2017 - 05:02 in Mathematics & Economics

Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net